These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 28388527

  • 21. Synthesis and characterization of glycyrrhizic acid coated iron oxide nanoparticles for hyperthermia applications.
    Saeedi M, Vahidi O, Bonakdar S.
    Mater Sci Eng C Mater Biol Appl; 2017 Aug 01; 77():1060-1067. PubMed ID: 28531979
    [Abstract] [Full Text] [Related]

  • 22. Biodistribution, pharmacokinetics, and toxicity of dendrimer-coated iron oxide nanoparticles in BALB/c mice.
    Salimi M, Sarkar S, Fathi S, Alizadeh AM, Saber R, Moradi F, Delavari H.
    Int J Nanomedicine; 2018 Aug 01; 13():1483-1493. PubMed ID: 29559777
    [Abstract] [Full Text] [Related]

  • 23. Suspension of Fe(3)O(4) nanoparticles stabilized by chitosan and o-carboxymethylchitosan.
    Zhu A, Yuan L, Liao T.
    Int J Pharm; 2008 Feb 28; 350(1-2):361-8. PubMed ID: 17931808
    [Abstract] [Full Text] [Related]

  • 24. Cytotoxic effects and apoptosis induction of cisplatin-loaded iron oxide nanoparticles modified with chitosan in human breast cancer cells.
    Morovati A, Ahmadian S, Jafary H.
    Mol Biol Rep; 2019 Oct 28; 46(5):5033-5039. PubMed ID: 31278563
    [Abstract] [Full Text] [Related]

  • 25. Core-shell drug carrier from folate conjugated chitosan obtained from prawn shell for targeted doxorubicin delivery.
    Islam MS, Haque P, Rashid TU, Khan MN, Mallik AK, Khan MN, Khan M, Rahman MM.
    J Mater Sci Mater Med; 2017 Apr 28; 28(4):55. PubMed ID: 28210967
    [Abstract] [Full Text] [Related]

  • 26. Iron oxide nanoparticles modulate lipopolysaccharide-induced inflammatory responses in primary human monocytes.
    Grosse S, Stenvik J, Nilsen AM.
    Int J Nanomedicine; 2016 Apr 28; 11():4625-4642. PubMed ID: 27695322
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The effect of neutral-surface iron oxide nanoparticles on cellular uptake and signaling pathways.
    Kim E, Kim JM, Kim L, Choi SJ, Park IS, Han JY, Chu YC, Choi ES, Na K, Hong SS.
    Int J Nanomedicine; 2016 Apr 28; 11():4595-4607. PubMed ID: 27695320
    [Abstract] [Full Text] [Related]

  • 29. Inactivation of Pseudomonas aeruginosa by Chitosan Coated Iron Oxide Nanoparticles.
    Mukherjee M, De S.
    Recent Pat Biotechnol; 2016 Apr 28; 10(1):133-139. PubMed ID: 27494734
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Iron oxide nanoparticles induce cytokine secretion in a complement-dependent manner in a human whole blood model.
    Wolf-Grosse S, Rokstad AM, Ali S, Lambris JD, Mollnes TE, Nilsen AM, Stenvik J.
    Int J Nanomedicine; 2017 Apr 28; 12():3927-3940. PubMed ID: 28579778
    [Abstract] [Full Text] [Related]

  • 32. Toxicity of bare and surfaced functionalized iron oxide nanoparticles towards microalgae.
    Toh PY, Tai WY, Ahmad AL, Lim JK, Chan DJ.
    Int J Phytoremediation; 2016 Apr 28; 18(6):643-50. PubMed ID: 26389846
    [Abstract] [Full Text] [Related]

  • 33. Preparation of biotic and abiotic iron oxide nanoparticles (IOnPs) and their properties and applications in heterogeneous catalytic oxidation.
    Jung H, Park H, Kim J, Lee JH, Hur HG, Myung NV, Choi H.
    Environ Sci Technol; 2007 Jul 01; 41(13):4741-7. PubMed ID: 17695923
    [Abstract] [Full Text] [Related]

  • 34. Investigating the toxic effects induced by iron oxide nanoparticles on neuroblastoma cell line: an integrative study combining cytotoxic, genotoxic and proteomic tools.
    Askri D, Cunin V, Béal D, Berthier S, Chovelon B, Arnaud J, Rachidi W, Sakly M, Amara S, Sève M, Lehmann SG.
    Nanotoxicology; 2019 Oct 01; 13(8):1021-1040. PubMed ID: 31132913
    [Abstract] [Full Text] [Related]

  • 35. Antioxidant Iron Oxide Nanoparticles: Their Biocompatibility and Bioactive Properties.
    Lee J, Lee JH, Lee SY, Park SA, Kim JH, Hwang D, Kim KA, Kim HS.
    Int J Mol Sci; 2023 Nov 02; 24(21):. PubMed ID: 37958885
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Limitations and caveats of magnetic cell labeling using transfection agent complexed iron oxide nanoparticles.
    Soenen SJ, De Smedt SC, Braeckmans K.
    Contrast Media Mol Imaging; 2012 Nov 02; 7(2):140-52. PubMed ID: 22434626
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.